nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Palmar erythema—Vemurafenib—skin cancer	0.121	0.279	CcSEcCtD
Acetylcysteine—SLC7A11—forelimb zeugopod—skin cancer	0.0646	0.224	CbGeAlD
Acetylcysteine—GRIN2B—nerve—skin cancer	0.0188	0.0654	CbGeAlD
Acetylcysteine—GRIN2A—nerve—skin cancer	0.0165	0.0572	CbGeAlD
Acetylcysteine—GSS—hair follicle—skin cancer	0.0121	0.0419	CbGeAlD
Acetylcysteine—ACY1—skin of body—skin cancer	0.0114	0.0395	CbGeAlD
Acetylcysteine—ACY1—female reproductive system—skin cancer	0.00888	0.0308	CbGeAlD
Acetylcysteine—CHUK—connective tissue—skin cancer	0.00869	0.0302	CbGeAlD
Acetylcysteine—IKBKB—nipple—skin cancer	0.00833	0.0289	CbGeAlD
Acetylcysteine—CHUK—epithelium—skin cancer	0.00825	0.0286	CbGeAlD
Acetylcysteine—GSS—nipple—skin cancer	0.00817	0.0284	CbGeAlD
Acetylcysteine—Feeling hot—Imiquimod—skin cancer	0.00789	0.0183	CcSEcCtD
Acetylcysteine—CHUK—skin of body—skin cancer	0.00785	0.0272	CbGeAlD
Acetylcysteine—ACY1—head—skin cancer	0.00742	0.0258	CbGeAlD
Acetylcysteine—CHUK—lymphoid tissue—skin cancer	0.00635	0.0221	CbGeAlD
Acetylcysteine—CHUK—female reproductive system—skin cancer	0.00613	0.0213	CbGeAlD
Acetylcysteine—IKBKB—connective tissue—skin cancer	0.00591	0.0205	CbGeAlD
Acetylcysteine—Gastrointestinal symptom NOS—Fluorouracil—skin cancer	0.00582	0.0135	CcSEcCtD
Acetylcysteine—IKBKB—skin of body—skin cancer	0.00533	0.0185	CbGeAlD
Acetylcysteine—Chest tightness—Docetaxel—skin cancer	0.00527	0.0122	CcSEcCtD
Acetylcysteine—GRIN2D—head—skin cancer	0.00525	0.0182	CbGeAlD
Acetylcysteine—GSS—skin of body—skin cancer	0.00523	0.0182	CbGeAlD
Acetylcysteine—CHUK—head—skin cancer	0.00512	0.0178	CbGeAlD
Acetylcysteine—SLC7A11—female reproductive system—skin cancer	0.00505	0.0175	CbGeAlD
Acetylcysteine—GRIN3A—head—skin cancer	0.00494	0.0172	CbGeAlD
Acetylcysteine—IKBKB—mammalian vulva—skin cancer	0.00486	0.0169	CbGeAlD
Acetylcysteine—GSS—mammalian vulva—skin cancer	0.00477	0.0166	CbGeAlD
Acetylcysteine—GRIN1—head—skin cancer	0.00468	0.0163	CbGeAlD
Acetylcysteine—GRIN2B—head—skin cancer	0.00447	0.0155	CbGeAlD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00435	0.0101	CcSEcCtD
Acetylcysteine—Face oedema—Imiquimod—skin cancer	0.00434	0.0101	CcSEcCtD
Acetylcysteine—IKBKB—lymphoid tissue—skin cancer	0.00432	0.015	CbGeAlD
Acetylcysteine—Wheezing—Bleomycin—skin cancer	0.00428	0.0099	CcSEcCtD
Acetylcysteine—SLC7A11—head—skin cancer	0.00422	0.0146	CbGeAlD
Acetylcysteine—IKBKB—female reproductive system—skin cancer	0.00417	0.0145	CbGeAlD
Acetylcysteine—GSS—female reproductive system—skin cancer	0.00409	0.0142	CbGeAlD
Acetylcysteine—Skin disorder—Vismodegib—skin cancer	0.00408	0.00943	CcSEcCtD
Acetylcysteine—GRIN2A—head—skin cancer	0.0039	0.0136	CbGeAlD
Acetylcysteine—Gait disturbance—Temozolomide—skin cancer	0.0038	0.00881	CcSEcCtD
Acetylcysteine—Dyspepsia—Vismodegib—skin cancer	0.00369	0.00855	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00362	0.00839	CcSEcCtD
Acetylcysteine—CHUK—lymph node—skin cancer	0.00358	0.0124	CbGeAlD
Acetylcysteine—IKBKB—head—skin cancer	0.00348	0.0121	CbGeAlD
Acetylcysteine—GSS—head—skin cancer	0.00342	0.0119	CbGeAlD
Acetylcysteine—Cardiac disorder—Vemurafenib—skin cancer	0.00339	0.00784	CcSEcCtD
Acetylcysteine—Angiopathy—Vemurafenib—skin cancer	0.00331	0.00766	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Vemurafenib—skin cancer	0.00329	0.00761	CcSEcCtD
Acetylcysteine—Mental disability—Temozolomide—skin cancer	0.00322	0.00746	CcSEcCtD
Acetylcysteine—Erythema—Vemurafenib—skin cancer	0.00318	0.00735	CcSEcCtD
Acetylcysteine—Ear pain—Temozolomide—skin cancer	0.00316	0.00731	CcSEcCtD
Acetylcysteine—Pharyngitis—Imiquimod—skin cancer	0.00309	0.00715	CcSEcCtD
Acetylcysteine—Rhinorrhoea—Docetaxel—skin cancer	0.00305	0.00706	CcSEcCtD
Acetylcysteine—SLCO1B1—female reproductive system—skin cancer	0.003	0.0104	CbGeAlD
Acetylcysteine—Eye pain—Temozolomide—skin cancer	0.00299	0.00691	CcSEcCtD
Acetylcysteine—Pruritus—Vismodegib—skin cancer	0.00297	0.00687	CcSEcCtD
Acetylcysteine—Flushing—Imiquimod—skin cancer	0.00289	0.00669	CcSEcCtD
Acetylcysteine—Angiopathy—Imiquimod—skin cancer	0.00282	0.00654	CcSEcCtD
Acetylcysteine—Immune system disorder—Imiquimod—skin cancer	0.00281	0.00651	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Imiquimod—skin cancer	0.0028	0.00649	CcSEcCtD
Acetylcysteine—Chest discomfort—Docetaxel—skin cancer	0.00279	0.00646	CcSEcCtD
Acetylcysteine—Cough—Vemurafenib—skin cancer	0.00277	0.00642	CcSEcCtD
Acetylcysteine—Bronchospasm—Bleomycin—skin cancer	0.00272	0.00629	CcSEcCtD
Acetylcysteine—Erythema—Imiquimod—skin cancer	0.00271	0.00627	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00269	0.00622	CcSEcCtD
Acetylcysteine—Vomiting—Vismodegib—skin cancer	0.00267	0.00618	CcSEcCtD
Acetylcysteine—Rash—Vismodegib—skin cancer	0.00265	0.00612	CcSEcCtD
Acetylcysteine—Dermatitis—Vismodegib—skin cancer	0.00264	0.00612	CcSEcCtD
Acetylcysteine—Face oedema—Temozolomide—skin cancer	0.0026	0.00602	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Vemurafenib—skin cancer	0.00259	0.006	CcSEcCtD
Acetylcysteine—Skin disorder—Vemurafenib—skin cancer	0.00252	0.00583	CcSEcCtD
Acetylcysteine—Nausea—Vismodegib—skin cancer	0.00249	0.00577	CcSEcCtD
Acetylcysteine—Angioedema—Imiquimod—skin cancer	0.00248	0.00573	CcSEcCtD
Acetylcysteine—IKBKB—lymph node—skin cancer	0.00244	0.00846	CbGeAlD
Acetylcysteine—Syncope—Imiquimod—skin cancer	0.00243	0.00562	CcSEcCtD
Acetylcysteine—Hypotension—Vemurafenib—skin cancer	0.00242	0.00561	CcSEcCtD
Acetylcysteine—Stomatitis—Bleomycin—skin cancer	0.0024	0.00556	CcSEcCtD
Acetylcysteine—GSS—lymph node—skin cancer	0.00239	0.00831	CbGeAlD
Acetylcysteine—Loss of consciousness—Imiquimod—skin cancer	0.00238	0.00551	CcSEcCtD
Acetylcysteine—Cough—Imiquimod—skin cancer	0.00236	0.00547	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00229	0.0053	CcSEcCtD
Acetylcysteine—Stomatitis—Dactinomycin—skin cancer	0.00224	0.00518	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00224	0.00518	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Fluorouracil—skin cancer	0.00222	0.00514	CcSEcCtD
Acetylcysteine—Oedema—Imiquimod—skin cancer	0.00221	0.00512	CcSEcCtD
Acetylcysteine—Shock—Imiquimod—skin cancer	0.00218	0.00504	CcSEcCtD
Acetylcysteine—Tachycardia—Imiquimod—skin cancer	0.00216	0.00499	CcSEcCtD
Acetylcysteine—Skin disorder—Imiquimod—skin cancer	0.00215	0.00497	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Imiquimod—skin cancer	0.00214	0.00495	CcSEcCtD
Acetylcysteine—Flushing—Bleomycin—skin cancer	0.00205	0.00475	CcSEcCtD
Acetylcysteine—Body temperature increased—Vemurafenib—skin cancer	0.00205	0.00474	CcSEcCtD
Acetylcysteine—Pharyngitis—Dactinomycin—skin cancer	0.00205	0.00474	CcSEcCtD
Acetylcysteine—Stomatitis—Temozolomide—skin cancer	0.00202	0.00469	CcSEcCtD
Acetylcysteine—Dyspnoea—Imiquimod—skin cancer	0.00197	0.00456	CcSEcCtD
Acetylcysteine—Somnolence—Imiquimod—skin cancer	0.00197	0.00455	CcSEcCtD
Acetylcysteine—Dyspepsia—Imiquimod—skin cancer	0.00195	0.0045	CcSEcCtD
Acetylcysteine—Erythema—Bleomycin—skin cancer	0.00192	0.00445	CcSEcCtD
Acetylcysteine—Flushing—Dactinomycin—skin cancer	0.00191	0.00443	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vemurafenib—skin cancer	0.00191	0.00442	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00191	0.00442	CcSEcCtD
Acetylcysteine—Stomatitis—Fluorouracil—skin cancer	0.00187	0.00432	CcSEcCtD
Acetylcysteine—Pharyngitis—Temozolomide—skin cancer	0.00185	0.00428	CcSEcCtD
Acetylcysteine—Pruritus—Vemurafenib—skin cancer	0.00183	0.00425	CcSEcCtD
Acetylcysteine—Erythema—Dactinomycin—skin cancer	0.00179	0.00415	CcSEcCtD
Acetylcysteine—Urticaria—Imiquimod—skin cancer	0.00176	0.00407	CcSEcCtD
Acetylcysteine—Body temperature increased—Imiquimod—skin cancer	0.00175	0.00405	CcSEcCtD
Acetylcysteine—Flushing—Temozolomide—skin cancer	0.00173	0.00401	CcSEcCtD
Acetylcysteine—Cardiac disorder—Temozolomide—skin cancer	0.00173	0.00401	CcSEcCtD
Acetylcysteine—Dizziness—Vemurafenib—skin cancer	0.00171	0.00397	CcSEcCtD
Acetylcysteine—Pharyngitis—Fluorouracil—skin cancer	0.00171	0.00395	CcSEcCtD
Acetylcysteine—Angiopathy—Temozolomide—skin cancer	0.00169	0.00392	CcSEcCtD
Acetylcysteine—Immune system disorder—Temozolomide—skin cancer	0.00168	0.0039	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Temozolomide—skin cancer	0.00168	0.00389	CcSEcCtD
Acetylcysteine—Cough—Bleomycin—skin cancer	0.00168	0.00389	CcSEcCtD
Acetylcysteine—Vomiting—Vemurafenib—skin cancer	0.00165	0.00382	CcSEcCtD
Acetylcysteine—Rash—Vemurafenib—skin cancer	0.00163	0.00378	CcSEcCtD
Acetylcysteine—Dermatitis—Vemurafenib—skin cancer	0.00163	0.00378	CcSEcCtD
Acetylcysteine—Hypersensitivity—Imiquimod—skin cancer	0.00163	0.00377	CcSEcCtD
Acetylcysteine—Erythema—Temozolomide—skin cancer	0.00162	0.00376	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Docetaxel—skin cancer	0.0016	0.00371	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Bleomycin—skin cancer	0.00157	0.00364	CcSEcCtD
Acetylcysteine—Oedema—Bleomycin—skin cancer	0.00157	0.00364	CcSEcCtD
Acetylcysteine—Pruritus—Imiquimod—skin cancer	0.00156	0.00362	CcSEcCtD
Acetylcysteine—Nausea—Vemurafenib—skin cancer	0.00154	0.00356	CcSEcCtD
Acetylcysteine—Bronchospasm—Docetaxel—skin cancer	0.00152	0.00353	CcSEcCtD
Acetylcysteine—Erythema—Fluorouracil—skin cancer	0.0015	0.00346	CcSEcCtD
Acetylcysteine—Angioedema—Temozolomide—skin cancer	0.00148	0.00343	CcSEcCtD
Acetylcysteine—Hypotension—Bleomycin—skin cancer	0.00147	0.0034	CcSEcCtD
Acetylcysteine—Oedema—Dactinomycin—skin cancer	0.00146	0.00339	CcSEcCtD
Acetylcysteine—Dizziness—Imiquimod—skin cancer	0.00146	0.00338	CcSEcCtD
Acetylcysteine—Cough—Temozolomide—skin cancer	0.00142	0.00328	CcSEcCtD
Acetylcysteine—Vomiting—Imiquimod—skin cancer	0.00141	0.00325	CcSEcCtD
Acetylcysteine—Dyspnoea—Bleomycin—skin cancer	0.0014	0.00324	CcSEcCtD
Acetylcysteine—Rash—Imiquimod—skin cancer	0.00139	0.00323	CcSEcCtD
Acetylcysteine—Dermatitis—Imiquimod—skin cancer	0.00139	0.00322	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00137	0.00318	CcSEcCtD
Acetylcysteine—Stomatitis—Docetaxel—skin cancer	0.00135	0.00312	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Temozolomide—skin cancer	0.00132	0.00307	CcSEcCtD
Acetylcysteine—Oedema—Temozolomide—skin cancer	0.00132	0.00307	CcSEcCtD
Acetylcysteine—Nausea—Imiquimod—skin cancer	0.00131	0.00304	CcSEcCtD
Acetylcysteine—Skin disorder—Temozolomide—skin cancer	0.00129	0.00298	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Temozolomide—skin cancer	0.00128	0.00296	CcSEcCtD
Acetylcysteine—Urticaria—Bleomycin—skin cancer	0.00125	0.00289	CcSEcCtD
Acetylcysteine—Body temperature increased—Bleomycin—skin cancer	0.00124	0.00287	CcSEcCtD
Acetylcysteine—Pharyngitis—Docetaxel—skin cancer	0.00123	0.00285	CcSEcCtD
Acetylcysteine—Oedema—Fluorouracil—skin cancer	0.00122	0.00283	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Fluorouracil—skin cancer	0.00122	0.00283	CcSEcCtD
Acetylcysteine—Tachycardia—Fluorouracil—skin cancer	0.00119	0.00276	CcSEcCtD
Acetylcysteine—Dyspnoea—Temozolomide—skin cancer	0.00118	0.00273	CcSEcCtD
Acetylcysteine—Somnolence—Temozolomide—skin cancer	0.00118	0.00273	CcSEcCtD
Acetylcysteine—Dyspepsia—Temozolomide—skin cancer	0.00117	0.0027	CcSEcCtD
Acetylcysteine—Body temperature increased—Dactinomycin—skin cancer	0.00116	0.00268	CcSEcCtD
Acetylcysteine—Hypersensitivity—Bleomycin—skin cancer	0.00116	0.00268	CcSEcCtD
Acetylcysteine—Cardiac disorder—Docetaxel—skin cancer	0.00115	0.00266	CcSEcCtD
Acetylcysteine—Flushing—Docetaxel—skin cancer	0.00115	0.00266	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00114	0.00265	CcSEcCtD
Acetylcysteine—Hypotension—Fluorouracil—skin cancer	0.00114	0.00264	CcSEcCtD
Acetylcysteine—Angiopathy—Docetaxel—skin cancer	0.00113	0.0026	CcSEcCtD
Acetylcysteine—Immune system disorder—Docetaxel—skin cancer	0.00112	0.00259	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Docetaxel—skin cancer	0.00112	0.00259	CcSEcCtD
Acetylcysteine—Pruritus—Bleomycin—skin cancer	0.00111	0.00257	CcSEcCtD
Acetylcysteine—Dyspnoea—Fluorouracil—skin cancer	0.00109	0.00252	CcSEcCtD
Acetylcysteine—Somnolence—Fluorouracil—skin cancer	0.00109	0.00251	CcSEcCtD
Acetylcysteine—Erythema—Docetaxel—skin cancer	0.00108	0.0025	CcSEcCtD
Acetylcysteine—Hypersensitivity—Dactinomycin—skin cancer	0.00108	0.0025	CcSEcCtD
Acetylcysteine—Dyspepsia—Fluorouracil—skin cancer	0.00107	0.00249	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00105	0.00244	CcSEcCtD
Acetylcysteine—Urticaria—Temozolomide—skin cancer	0.00105	0.00244	CcSEcCtD
Acetylcysteine—Body temperature increased—Temozolomide—skin cancer	0.00105	0.00242	CcSEcCtD
Acetylcysteine—Vomiting—Bleomycin—skin cancer	0.000999	0.00231	CcSEcCtD
Acetylcysteine—Rash—Bleomycin—skin cancer	0.00099	0.00229	CcSEcCtD
Acetylcysteine—Dermatitis—Bleomycin—skin cancer	0.000989	0.00229	CcSEcCtD
Acetylcysteine—Hypersensitivity—Temozolomide—skin cancer	0.000976	0.00226	CcSEcCtD
Acetylcysteine—Urticaria—Fluorouracil—skin cancer	0.00097	0.00224	CcSEcCtD
Acetylcysteine—Syncope—Docetaxel—skin cancer	0.000968	0.00224	CcSEcCtD
Acetylcysteine—Body temperature increased—Fluorouracil—skin cancer	0.000965	0.00223	CcSEcCtD
Acetylcysteine—Loss of consciousness—Docetaxel—skin cancer	0.000949	0.0022	CcSEcCtD
Acetylcysteine—Cough—Docetaxel—skin cancer	0.000942	0.00218	CcSEcCtD
Acetylcysteine—Pruritus—Temozolomide—skin cancer	0.000937	0.00217	CcSEcCtD
Acetylcysteine—Nausea—Bleomycin—skin cancer	0.000933	0.00216	CcSEcCtD
Acetylcysteine—Vomiting—Dactinomycin—skin cancer	0.000931	0.00216	CcSEcCtD
Acetylcysteine—Rash—Dactinomycin—skin cancer	0.000924	0.00214	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000913	0.00211	CcSEcCtD
Acetylcysteine—Hypersensitivity—Fluorouracil—skin cancer	0.000899	0.00208	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Docetaxel—skin cancer	0.000881	0.00204	CcSEcCtD
Acetylcysteine—Oedema—Docetaxel—skin cancer	0.000881	0.00204	CcSEcCtD
Acetylcysteine—Dizziness—Temozolomide—skin cancer	0.000876	0.00203	CcSEcCtD
Acetylcysteine—Nausea—Dactinomycin—skin cancer	0.00087	0.00201	CcSEcCtD
Acetylcysteine—Shock—Docetaxel—skin cancer	0.000867	0.00201	CcSEcCtD
Acetylcysteine—Pruritus—Fluorouracil—skin cancer	0.000864	0.002	CcSEcCtD
Acetylcysteine—Tachycardia—Docetaxel—skin cancer	0.00086	0.00199	CcSEcCtD
Acetylcysteine—Skin disorder—Docetaxel—skin cancer	0.000856	0.00198	CcSEcCtD
Acetylcysteine—Vomiting—Temozolomide—skin cancer	0.000842	0.00195	CcSEcCtD
Acetylcysteine—Rash—Temozolomide—skin cancer	0.000835	0.00193	CcSEcCtD
Acetylcysteine—Dermatitis—Temozolomide—skin cancer	0.000835	0.00193	CcSEcCtD
Acetylcysteine—Hypotension—Docetaxel—skin cancer	0.000823	0.00191	CcSEcCtD
Acetylcysteine—Dizziness—Fluorouracil—skin cancer	0.000807	0.00187	CcSEcCtD
Acetylcysteine—Nausea—Temozolomide—skin cancer	0.000787	0.00182	CcSEcCtD
Acetylcysteine—Dyspnoea—Docetaxel—skin cancer	0.000785	0.00182	CcSEcCtD
Acetylcysteine—Somnolence—Docetaxel—skin cancer	0.000783	0.00181	CcSEcCtD
Acetylcysteine—Vomiting—Fluorouracil—skin cancer	0.000776	0.0018	CcSEcCtD
Acetylcysteine—Dyspepsia—Docetaxel—skin cancer	0.000776	0.0018	CcSEcCtD
Acetylcysteine—Rash—Fluorouracil—skin cancer	0.00077	0.00178	CcSEcCtD
Acetylcysteine—Dermatitis—Fluorouracil—skin cancer	0.000769	0.00178	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000761	0.00176	CcSEcCtD
Acetylcysteine—Nausea—Fluorouracil—skin cancer	0.000725	0.00168	CcSEcCtD
Acetylcysteine—Body temperature increased—Docetaxel—skin cancer	0.000696	0.00161	CcSEcCtD
Acetylcysteine—Hypersensitivity—Docetaxel—skin cancer	0.000649	0.0015	CcSEcCtD
Acetylcysteine—Pruritus—Docetaxel—skin cancer	0.000623	0.00144	CcSEcCtD
Acetylcysteine—Dizziness—Docetaxel—skin cancer	0.000583	0.00135	CcSEcCtD
Acetylcysteine—Vomiting—Docetaxel—skin cancer	0.00056	0.0013	CcSEcCtD
Acetylcysteine—Rash—Docetaxel—skin cancer	0.000556	0.00129	CcSEcCtD
Acetylcysteine—Dermatitis—Docetaxel—skin cancer	0.000555	0.00128	CcSEcCtD
Acetylcysteine—Nausea—Docetaxel—skin cancer	0.000523	0.00121	CcSEcCtD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000277	0.000989	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL6—skin cancer	0.000276	0.000984	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—NRAS—skin cancer	0.000275	0.000981	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TLR7—skin cancer	0.000274	0.00098	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—HRAS—skin cancer	0.000271	0.000968	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—IL6—skin cancer	0.000271	0.000967	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000271	0.000967	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TP53—skin cancer	0.000271	0.000966	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—CDK4—skin cancer	0.000268	0.000957	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—FOXO4—skin cancer	0.000268	0.000956	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—skin cancer	0.000266	0.00095	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—KRAS—skin cancer	0.000265	0.000948	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—NRAS—skin cancer	0.000263	0.000939	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL6—skin cancer	0.000262	0.000937	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—skin cancer	0.000262	0.000934	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—CDK4—skin cancer	0.000261	0.000933	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—HRAS—skin cancer	0.000261	0.000932	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CSPG4—skin cancer	0.00026	0.000928	CbGpPWpGaD
Acetylcysteine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	0.000259	0.000925	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—NRAS—skin cancer	0.000259	0.000924	CbGpPWpGaD
Acetylcysteine—GRIN2A—Transmission across Chemical Synapses—HRAS—skin cancer	0.000258	0.00092	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—FOXO4—skin cancer	0.000257	0.000918	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—HRAS—skin cancer	0.000256	0.000916	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88-independent cascade—IL6—skin cancer	0.000255	0.000912	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	0.000254	0.000908	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL6—skin cancer	0.00025	0.000892	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000249	0.00089	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—HRAS—skin cancer	0.000249	0.000888	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—BRAF—skin cancer	0.000248	0.000887	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—PTGS2—skin cancer	0.000247	0.000883	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—NRAS—skin cancer	0.000247	0.000882	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—NRAS—skin cancer	0.000246	0.000878	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—HRAS—skin cancer	0.000246	0.000878	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—IL6—skin cancer	0.000245	0.000876	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000245	0.000876	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—NRAS—skin cancer	0.000245	0.000874	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—NRAS—skin cancer	0.000243	0.000869	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FOXO4—skin cancer	0.000243	0.000867	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—skin cancer	0.000241	0.000862	CbGpPWpGaD
Acetylcysteine—GRIN2D—Neuronal System—HRAS—skin cancer	0.00024	0.000858	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTCH2—skin cancer	0.00024	0.000857	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	0.00024	0.000857	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL6—skin cancer	0.000238	0.00085	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ERCC2—skin cancer	0.000237	0.000846	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—KRAS—skin cancer	0.000236	0.000844	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—FOXO4—skin cancer	0.000233	0.000832	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88-independent cascade—IL6—skin cancer	0.000231	0.000827	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—IL6—skin cancer	0.00023	0.00082	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—NRAS—skin cancer	0.000229	0.000818	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	0.000229	0.000818	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—NRAS—skin cancer	0.000229	0.000818	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—NRAS—skin cancer	0.000227	0.000811	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PLIN2—skin cancer	0.000226	0.000808	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—KRAS—skin cancer	0.000226	0.000808	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000226	0.000807	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—HRAS—skin cancer	0.000226	0.000806	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—BRAF—skin cancer	0.000225	0.000804	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—NRAS—skin cancer	0.000225	0.000803	CbGpPWpGaD
Acetylcysteine—GRIN1—Transmission across Chemical Synapses—HRAS—skin cancer	0.000225	0.000802	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—NRAS—skin cancer	0.000224	0.0008	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000224	0.000799	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—KRAS—skin cancer	0.000223	0.000795	CbGpPWpGaD
Acetylcysteine—GRIN2B—Transmission across Chemical Synapses—HRAS—skin cancer	0.000219	0.000782	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTCH2—skin cancer	0.000218	0.000777	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	0.000218	0.000777	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—NRAS—skin cancer	0.000217	0.000773	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	0.000216	0.000771	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL6—skin cancer	0.000216	0.000771	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—KRAS—skin cancer	0.000213	0.000759	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—NRAS—skin cancer	0.000212	0.000757	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—NRAS—skin cancer	0.000212	0.000757	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—KRAS—skin cancer	0.000212	0.000756	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—KRAS—skin cancer	0.000211	0.000752	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—KRAS—skin cancer	0.00021	0.000748	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—NRAS—skin cancer	0.000209	0.000745	CbGpPWpGaD
Acetylcysteine—IKBKB—Activated TLR4 signalling—IL6—skin cancer	0.000208	0.000744	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	0.000208	0.000742	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	0.000207	0.000737	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—NRAS—skin cancer	0.000204	0.000727	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—skin cancer	0.000203	0.000724	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—HRAS—skin cancer	0.000201	0.000718	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000199	0.00071	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—HRAS—skin cancer	0.000198	0.000706	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neuronal System—HRAS—skin cancer	0.000197	0.000705	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—KRAS—skin cancer	0.000197	0.000704	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—KRAS—skin cancer	0.000197	0.000704	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	0.000197	0.000704	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	0.000196	0.000699	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—KRAS—skin cancer	0.000195	0.000698	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000195	0.000695	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—KRAS—skin cancer	0.000194	0.000691	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—KRAS—skin cancer	0.000193	0.000688	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—IL6—skin cancer	0.000192	0.000687	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—IL6—skin cancer	0.000192	0.000687	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—HRAS—skin cancer	0.000192	0.000687	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—NRAS—skin cancer	0.000192	0.000686	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—HRAS—skin cancer	0.000189	0.000676	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	0.000187	0.000669	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—KRAS—skin cancer	0.000186	0.000666	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000185	0.000662	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—IL6—skin cancer	0.000184	0.000657	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CSPG4—skin cancer	0.000183	0.000652	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—KRAS—skin cancer	0.000182	0.000651	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—KRAS—skin cancer	0.000182	0.000651	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GLI2—skin cancer	0.000182	0.00065	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—IL6—skin cancer	0.000181	0.000647	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—HRAS—skin cancer	0.000181	0.000645	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—HRAS—skin cancer	0.00018	0.000642	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—KRAS—skin cancer	0.00018	0.000642	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—HRAS—skin cancer	0.000179	0.00064	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—HRAS—skin cancer	0.000179	0.000639	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	0.000179	0.000638	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—HRAS—skin cancer	0.000178	0.000636	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SHH—skin cancer	0.000177	0.000631	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ENO2—skin cancer	0.000177	0.000631	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000176	0.00063	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	0.000176	0.000627	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—KRAS—skin cancer	0.000175	0.000625	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	0.000175	0.000623	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—IL6—skin cancer	0.000174	0.000623	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MC1R—skin cancer	0.000174	0.00062	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—IL6—skin cancer	0.000173	0.000618	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—IL6—skin cancer	0.000172	0.000615	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—skin cancer	0.000172	0.000615	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—IL6—skin cancer	0.000171	0.000612	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GLI1—skin cancer	0.000171	0.000611	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—IL6—skin cancer	0.00017	0.000609	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—skin cancer	0.000168	0.000599	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—skin cancer	0.000168	0.000598	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—skin cancer	0.000168	0.000598	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	0.000168	0.000598	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—skin cancer	0.000166	0.000593	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—skin cancer	0.000166	0.000591	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KRAS—skin cancer	0.000165	0.000591	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GLI2—skin cancer	0.000165	0.000589	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000165	0.000589	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—skin cancer	0.000165	0.000588	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—skin cancer	0.000165	0.000588	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—skin cancer	0.000164	0.000585	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SUFU—skin cancer	0.000162	0.000579	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—skin cancer	0.000162	0.000579	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—IL6—skin cancer	0.00016	0.000573	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—IL6—skin cancer	0.00016	0.000573	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	0.00016	0.000573	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	0.000159	0.000568	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—IL6—skin cancer	0.000159	0.000568	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000159	0.000567	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—IL6—skin cancer	0.000158	0.000563	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MC1R—skin cancer	0.000157	0.000562	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—IL6—skin cancer	0.000157	0.00056	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NRAS—skin cancer	0.000156	0.000557	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FOXO4—skin cancer	0.000156	0.000557	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GLI1—skin cancer	0.000155	0.000554	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—skin cancer	0.000155	0.000554	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—skin cancer	0.000155	0.000554	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—skin cancer	0.000153	0.000545	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	0.000152	0.000543	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—NRAS—skin cancer	0.000149	0.000532	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—skin cancer	0.000149	0.000532	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	0.000148	0.00053	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SUFU—skin cancer	0.000147	0.000525	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—IL6—skin cancer	0.000146	0.000522	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	0.000145	0.000519	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—NRAS—skin cancer	0.000145	0.000519	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FOXO4—skin cancer	0.000144	0.000514	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000144	0.000514	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—IL6—skin cancer	0.000143	0.000509	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	0.000142	0.000507	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—skin cancer	0.000142	0.000507	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NRAS—skin cancer	0.000141	0.000505	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FOXO4—skin cancer	0.000141	0.000505	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—skin cancer	0.000141	0.000502	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000137	0.000488	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KRAS—skin cancer	0.000134	0.00048	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—skin cancer	0.000128	0.000458	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—skin cancer	0.000125	0.000446	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ENO2—skin cancer	0.000124	0.000443	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000124	0.000442	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SHH—skin cancer	0.000124	0.000442	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RASA1—skin cancer	0.000123	0.000439	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—skin cancer	0.000122	0.000435	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTCH1—skin cancer	0.000117	0.000419	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SMO—skin cancer	0.000117	0.000419	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—skin cancer	0.000116	0.000415	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—skin cancer	0.000114	0.000408	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTGER4—skin cancer	0.000114	0.000408	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SHH—skin cancer	0.000112	0.0004	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RASA1—skin cancer	0.000111	0.000398	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—skin cancer	0.000111	0.000397	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—skin cancer	0.000109	0.00039	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—skin cancer	0.000109	0.000389	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTCH1—skin cancer	0.000106	0.00038	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMO—skin cancer	0.000106	0.00038	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—skin cancer	0.000106	0.000379	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—skin cancer	0.000105	0.000376	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—skin cancer	0.000104	0.000372	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—skin cancer	0.000104	0.00037	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTGER4—skin cancer	0.000103	0.00037	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERCC2—skin cancer	0.000103	0.000366	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—skin cancer	0.000102	0.000363	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FOXO4—skin cancer	0.000101	0.00036	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—skin cancer	0.000101	0.00036	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—skin cancer	9.91e-05	0.000354	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.7e-05	0.000346	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TERT—skin cancer	9.62e-05	0.000343	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FOXO4—skin cancer	9.14e-05	0.000326	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—skin cancer	8.9e-05	0.000318	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—skin cancer	8.55e-05	0.000305	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—skin cancer	8.07e-05	0.000288	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—skin cancer	7.75e-05	0.000277	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—skin cancer	7.66e-05	0.000274	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—skin cancer	7.62e-05	0.000272	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—skin cancer	7.36e-05	0.000263	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ERCC2—skin cancer	7.21e-05	0.000257	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—skin cancer	6.95e-05	0.000248	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—skin cancer	6.73e-05	0.00024	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—skin cancer	6.67e-05	0.000238	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—skin cancer	6.51e-05	0.000232	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—skin cancer	6.25e-05	0.000223	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—skin cancer	6.23e-05	0.000223	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—skin cancer	6.15e-05	0.00022	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—skin cancer	6.11e-05	0.000218	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—skin cancer	5.9e-05	0.000211	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—skin cancer	5.67e-05	0.000202	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—skin cancer	5.65e-05	0.000202	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—skin cancer	5.33e-05	0.00019	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—skin cancer	5.18e-05	0.000185	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—skin cancer	4.84e-05	0.000173	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—skin cancer	4.79e-05	0.000171	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—skin cancer	4.7e-05	0.000168	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—skin cancer	4.46e-05	0.000159	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—skin cancer	4.32e-05	0.000154	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—skin cancer	4.12e-05	0.000147	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—skin cancer	4.05e-05	0.000144	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—skin cancer	3.79e-05	0.000135	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—skin cancer	3.63e-05	0.00013	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—skin cancer	3.5e-05	0.000125	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—skin cancer	3.44e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—skin cancer	3.35e-05	0.00012	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—skin cancer	3.35e-05	0.00012	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—skin cancer	3.29e-05	0.000118	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—skin cancer	3.04e-05	0.000109	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—skin cancer	2.88e-05	0.000103	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—skin cancer	2.62e-05	9.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—skin cancer	2.56e-05	9.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—skin cancer	2.45e-05	8.75e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—skin cancer	2.35e-05	8.38e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—skin cancer	2.32e-05	8.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—skin cancer	2.22e-05	7.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—skin cancer	2.13e-05	7.6e-05	CbGpPWpGaD
